MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.14359

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndrome.

Boerwinkle Anna H, Wisch Julie K, Handen Benjamin L, Head Elizabeth, Mapstone Mark, Rafii Michael S, O'Bryant Sid E, Krinsky-McHale Sharon J, Lai Florence, Rosas H Diana, Zaman Shahid, Lott Ira T, Tudorascu Dana, Zammit Matthew, Brickman Adam M, Lee Joseph H, Ances Beau M, Alzheimer's Biomarker Consortium‐Down Syndrome

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Development of Alzheimer's disease (AD) pathology in Down's syndrome (DS) occurs within a compressed timeline compared to sporadic or other genetic forms of AD.

METHODS

Plasma glial fibrillary acidic protein (GFAP) and plasma pTau-217 levels were compared by AD pathophysiology (amyloid (A+) and tau (T+) positron emission tomography [PET]) in persons with DS (N = 348) and sibling controls (N = 42). Plasma GFAP, plasma pTau-217, amyloid-PET, and tau-PET levels were compared with regard to estimated years to onset of clinical symptoms (52.5 years old). We evaluated if plasma GFAP mediated the relationship between amyloid PET and plasma pTau-217 or tau PET.

RESULTS

Plasma GFAP, a measure of astrogliosis, was elevated in A+/T- and A+/T+ individuals with DS. Plasma pTau-217 was elevated in A+/T+ individuals with DS. GFAP partially mediated the relationship between amyloid-PET and tau-PET (15.3%) and amyloid-PET and plasma pTau-217 (42.1%).

DISCUSSION: Astrogliosis is a key component in the advancement of preclinical AD pathophysiology in DS.

HIGHLIGHTS: Amyloid may be a necessary precursor for stimulating astrocytes. Astrogliosis may play a key role in modifications to tau phosphorylation. Targeting neuroinflammation may only aid amyloid positive individuals. Alzheimer's disease timecourse is compressed in individuals with Down's syndrome.

Для цитирования: Boerwinkle Anna H, Wisch Julie K, Handen Benjamin L, Head Elizabeth, Mapstone Mark, Rafii Michael S, O'Bryant Sid E, Krinsky-McHale Sharon J, Lai Florence, Rosas H Diana, Zaman Shahid, Lott Ira T, Tudorascu Dana, Zammit Matthew, Brickman Adam M, Lee Joseph H, Ances Beau M, Alzheimer's Biomarker Consortium‐Down Syndrome. The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndrome.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024. DOI: 10.1002/alz.14359.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.